Evidence map›Paper›PMID 31141957›Full record

ReviewInternational journal of molecular sciences2019

Recent Progress in TRPM8 Modulation: An Update.

Rosario González-Muñiz, M Angeles Bonache, Cristina Martín-Escura, Isabel Gómez-Monterrey

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. The therapeutic pipeline in migraine: What does the future hold?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1 signaling pathways and strengthening intestinal barrier function.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  14. Approaching Pharmacological Space: Events and Components.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rosario González-MuñizInstituto de Química Médica, IQM-CSIC. Juan de la Cierva 3, 28006 Madrid, Spain. rosario.gonzalezmuniz@iqm.csic.es.
M Angeles BonacheInstituto de Química Médica, IQM-CSIC. Juan de la Cierva 3, 28006 Madrid, Spain. angelesbonache@hotmail.com.ORCID 0000-0002-4922-5345
Cristina Martín-EscuraInstituto de Química Médica, IQM-CSIC. Juan de la Cierva 3, 28006 Madrid, Spain. cristinamartinescura@gmail.com.
Isabel Gómez-MonterreyDipartimento di Farmacia, Università "Federico II" de Napoli, Via D. Montesano 49, 80131 Naples, Italy. imgomez@unina.it.
Instituto de Química Médica · ESUniversity of Naples Federico II · IT

Funding

Consejo Superior de Investigaciones Científicas 201880E109, 201980E030Ministerio de Economía y Competitividad SAF2015-66275-C2-R
6 · The paper itself

Abstract

The transient receptor potential melastatin subtype 8 (TRPM8) is a nonselective, multimodal ion channel, activated by low temperatures (<28 °C), pressure, and cooling compounds (menthol, icilin). Experimental evidences indicated a role of TRPM8 in cold thermal transduction, different life-threatening tumors, and other pathologies, including migraine, urinary tract dysfunction, dry eye disease, and obesity. Hence, the modulation of the TRPM8 channel could be essential in order to understand its implications in these pathologies and for therapeutic intervention. This short review will cover recent progress on the TRPM8 agonists and antagonists, describing newly reported chemotypes, and their application in the pharmacological characterization of TRPM8 in health and disease. The recently described structures of the TRPM8 channel alone or complexed with known agonists and PIP

Indexed as

AnimalsBinding SitesHumansMembrane Transport ModulatorsProtein BindingTRPM Cation ChannelsMembrane Transport ModulatorsTRPM Cation ChannelsagonistsantagonistsstructureTRPM8

Identifiers

PMID31141957
PMCPMC6600640
OpenAlexW2946938349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.